COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 1037: Articles 10361-10370  | Next

A method for variant agnostic detection of SARS-CoV-2, rapid monitoring of circulating variants, detection of mutations of biological significance, and early detection of emergent variants such as Omicron
Lai, E., Becker, D., Brzoska, P., Cassens, T., Davis-Turak, J., Diamond, E., Furtado, M., Gandhi, M., Gort, D., Greninger, A. L., Hajian, P., Hayashibara, K., Kennedy, E. B., Laurent, M., Lee, W., Leonetti, N. A., Lozach, J., Lu, J., Nguyen, J. M., O'Donovan, K. M. C., Peck, T., Radcliffe, G. E., Ramirez, J. M., Roychoudhury, P., Sandoval, E., Walsh, B., Weinell, M., Wesselman, C., Wesselman, T., White, S., Williams, S., Wong, D., Yu, Y., Creager, R. S.
10.1101/2022.01.08.22268865 — Posted: 2022-01-09
Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19
M C, A., Singh, A. K., Pal, D., Das, K., Gajjala, A., Venkateshan, M., Mishra, B., Patro, B. K., Mohapatra, P. R., Subba, S. H.
10.1101/2022.01.04.21268536 — Posted: 2022-01-08 Discussion: Onsite
Comprehensive analysis of disease pathology in immunocompetent and immunocompromised hamster models of SARS-CoV-2 infection
Ramasamy, S., Kolloli, A., Kumar, R., Hussain, S., Soteropoulos, P., Chang, T., Subbian, S.
10.1101/2022.01.07.475406 — Posted: 2022-01-08
VarLOCK - sequencing independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance
Nan, X., Hoehn, S., Hardinge, P., Dighe, S. N., Ukeri, J., Pease, D., Griffin, J., Warrington, J. I., Saud, Z., Hottinger, E., Webster, G., Jones, D. L., Kille, P., Weightman, A., Stanton, R., Castell, O. K., Murray, J. A., Jurkowski, T. P.
10.1101/2022.01.06.21268555 — Posted: 2022-01-08
Temporary hold of mycophenolate boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients
Schrezenmeier, E., Rincon-Arevalo, H., Jens, A., Stefanski, A.-L., Hammett, C., Osmanodja, B., Koch, N., Zukunft, B., Beck, J., Oellerich, M., Pross, V., Stahl, C., Choi, M., Bachmann, F., Liefeldt, L., Glander, P., Schuetz, E., Bornemann-Kolatzki, K., Lopez del Moral, C., Schrezenmeier, H., Ludwig, C., Jahrdoerfer, B., Eckardt, K. U., Lachmann, N., Kotsch, K., Doerner, T., Halleck, F., Sattler, A., Budde, K.
10.1101/2022.01.05.21268478 — Posted: 2022-01-08
Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19
Pickering, C., Zhou, B., Xu, G., Rice, R., Huang, H., Pham, T., Shapiro, J., Cong, X., Chakraborty, S., Edwards, K., Reddy, S., Giurgis, F., Wang, T. T., Serie, D., Lindpaintner, K.
10.1101/2022.01.07.21267956 — Posted: 2022-01-08
Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants
Tseng, H. F., Ackerson, B. K., Luo, Y., Sy, L. S., Talarico, C., Tian, Y., Bruxvoort, K., Tupert, J. E., Florea, A., Ku, J. H., Lee, G. S., Choi, S. K., Takhar, H. S., Aragones, M., Qian, L.
10.1101/2022.01.07.22268919 — Posted: 2022-01-08 Discussion: Onsite
Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial
Vadrevu, K. M., Ganneru, B., Reddy, S., Jogdand, H., Dugyala, R., Praturi, U., Sapkal, G. N., Yadav, P., Reddy, P., Verma, S., Singh, C., Redkar, S. V., Gillurkar, C. S., Kushwaha, J. S., Mohapatra, S., Bhate, A., Rai, S., Ella, R., Abraham, P., Prasad, S., Ella, K.
10.1101/2022.01.05.22268777 — Posted: 2022-01-08
BNT162b2 post-exposure-prophylaxis against COVID-19
Shemuelian, Z., Warszawer, Y., Or, O., Arbel-Alon, S., Giladi, H., Avgil Tsadok, M., Cohen, R., Shefer, G., Maruotti, A., Jona Lasinio, G., Galun, E.
10.1101/2022.01.07.22268869 — Posted: 2022-01-08 Discussion: Onsite
The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule
Colson, P., Gautret, p., Delerce, J., Chaudet, H., Pontarotti, P., Forterre, P., Tola, R., Bedotto, M., Delorme, L., LEVASSEUR, A., Lagier, J.-C., Million, M., Yahi, N., Fantini, J., La Scola, B., Fournier, P.-E., Raoult, D.
10.1101/2022.01.04.22268715 — Posted: 2022-01-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).